Skip to content
Screener

Arbutus Biopharma Corporation ABUS Preferred Stock, Shares Authorized

Preferred Stock, Shares Authorized at other companies

Avalo Therapeutics logo
Avalo TherapeuticsAVTX
$5M
Vir Biotechnology, Inc. logo
Vir Biotechnology, Inc.VIR
$10M0.0%
Lantheus Holdings logo
Lantheus HoldingsLNTH
$25M0.0%
Ligand Pharmaceuticals logo
Ligand PharmaceuticalsLGND
$5M0.0%
BioCryst Pharmaceuticals logo
BioCryst PharmaceuticalsBCRX
$5M0.0%
ALN
Alnylam PharmaceuticalsALNY

Other financials

Income statement

See full
Revenue$1.0M-90.6%
Operating income-$6.0M-501%
Net income-$5.1M-304%
EPS (diluted)-$0.03-400%

Balance sheet

See full
Cash & equivalents$19.2M-48.8%
Total debt$514.0K-52.8%
Total equity$258.7M+212%
Total assets$274.0M+165%

Cash flow

See full
Operating cash flow-$6.0M+61.8%
CapEx--100%
Free cash flow-$4.7M+55.0%

Valuation

See full
Market cap$906.7M+41.2%
Enterprise value$888.04M+46.6%
P/E5.9×
P/S-36.7×

Profitability

See full
Operating margin82%+44.9pp
Net margin84.2%+46.6pp
FCF margin-281.5%-119pp

Returns & leverage

See full
Return on equity89.6%+65.3pp
Debt / equity0.0×
Current ratio81.4×+60.9×

Where this comes from

Reported directly by Arbutus Biopharma Corporation in its filing.

Tagged under the XBRL concept us-gaap:PreferredStockSharesAuthorized.

The source filing: Arbutus Biopharma Corporation’s 10-Q, filed August 12, 2026.

Filed
Aug 12, 2026, 7:31 AM EDT
Fiscal quarter
Q3 FY2026
Calendar quarter
Q3 2026
Accession
0001447028-26-000045

The Company’s authorized share capital consists of an unlimited number of common shares and preferred shares, without par value, and 1,164,000 Series A participating convertible preferred shares, without par value.

ITEM 1. FINANCIAL STATEMENTS (UNAUDITED)

FAQ

What is Arbutus Biopharma Corporation's preferred stock, shares authorized?
Arbutus Biopharma Corporation (ABUS) reported preferred stock, shares authorized of $1.16M in Q2 2026.
How has Arbutus Biopharma Corporation's preferred stock, shares authorized changed year-over-year?
Arbutus Biopharma Corporation's preferred stock, shares authorized decreased by 0.0% year-over-year, from $1.16M to $1.16M.
What does preferred stock, shares authorized mean?
Preferred Stock, Shares Authorized

Ask your AI about Arbutus Biopharma Corporation's preferred stock, shares authorized.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude